| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |